NCT/Study#
N/A /
BENDAMUSTINE-CART-OUTCOMES
Impact of Bendamustine as an Alternative Lymphodepletion Regimen on Chimeric Antigen Receptor T-Cell Therapy Outcomes
DISEASE GROUP:
Bone Marrow Transplant
current phase:
N/A
STUDY STATUS:
Enrolling
Location:
Hackensack, NJ
For More information:
